registrieren | anmelden | FAQ      [?] 

Tag epo [66 articles]

Recent papers classified by the tag epo.
  • Elevated erythropoietin mRNA and protein concentrations in the developing human eye.
    Pediatric research, Vol. 63, No. 4. (April 2008), pp. 394-397.
    by S Patel, MJ Rowe, SA Winters, RK Ohls
    posted to epo by ykaminoh on 2008-06-23 18:53:59 as **
  • Erythropoietin deficiency decreases vascular stability in mice.
    The Journal of clinical investigation, Vol. 118, No. 2. (February 2008), pp. 526-533.
    by J Chen, KM Connor, CM Aderman, LE Smith
    posted to epo by ykaminoh on 2008-06-23 18:55:00 as ** along with 1 person cchand
  • Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
    Proceedings of the National Academy of Sciences, Vol. 105, No. 19. (13 May 2008), pp. 6998-7003.
    by Zongzhong Tong, Zhenglin Yang, Shrena Patel, Haoyu Chen, Daniel Gibbs, Xian Yang, Vincent S Hau, Yuuki Kaminoh, Jennifer Harmon, Erik Pearson, Jeanette Buehler, Yuhong Chen, Baifeng Yu, Nicholas H Tinkham, Norman A Zabriskie, Jiexi Zeng, Ling Luo, Jennifer K Sun, Manvi Prakash, Rola N Hamam, Stephen Tonna, Ryan Constantine, Cecinio C Ronquillo, Srinivas Sadda, Robert L Avery, John M Brand, Nyall London, Alfred L Anduze, George L King, Paul S Bernstein, Scott Watkins, Genetics, Lynn B Jorde, Dean Y Li, Lloyd P Aiello, Martin R Pollak, Kang Zhang
    posted to epo by ykaminoh on 2008-05-20 20:08:16 as ***** along with 3 people vassadda oelemento jyuh
  • Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
    Nat Clin Pract Neph, Vol. 4, No. 1. (January 2008), pp. 47-57.
    by Karien van der Putten, Branko Braam, Kim E Jie, Carlo AJM Gaillard
    posted to epo heart_failure mechanism renal_failure by yavanna on 2008-01-07 12:12:40 as ***
  • Critical missing data on erythropoiesis-stimulating agents in CKD: first beat placebo.
    Am J Kidney Dis, Vol. 51, No. 3. (March 2008), pp. 366-369.
    by MA Pfeffer
    posted to ckd epo rct by jyuh on 2008-03-03 02:33:58 as **
  • Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients
    Nephrology Dialysis Transplantation, Vol. 21, No. 4. (April 2006), pp. 991-998.
    by Francesco Locatelli, Simeone Andrulli, Bruno Memoli, Camilla Maffei, Lucia Del Vecchio, Stefano Aterini, Walter De Simone, Antonella Mandalari, Giuliano Brunori, Marcello Amato, Bruno Cianciaruso, Carmine Zoccali
    posted to epo inflammation nutrition hd by jyuh on 2008-06-27 05:07:13 as **
  • Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
    Transplantation proceedings, Vol. 39, No. 10. (December 2007), pp. 3035-3040.
    posted to crp epo hd inflammation ros by jyuh on 2008-07-08 04:03:58 as **
  • Hemoglobin variability in dialysis patients.
    J Am Soc Nephrol, Vol. 18, No. 8. (August 2007), pp. 2218-2220.
    by KS Brimble, CM Clase
    posted to anemia epo hd variability by jyuh on 2007-09-29 03:05:27 as **
  • Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients.
    Nephrol Dial Transplant, Vol. 22, No. 12. (December 2007), pp. 3586-3592.
    posted to cytokine epo hd snp by jyuh on 2008-02-14 09:03:55 as **
  • Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
    Clin J Am Soc Nephrol, Vol. 3, No. 1. (January 2008), pp. 98-104.
    by R Agarwal, JL Davis, L Smith
    posted to albumin epo hd by jyuh on 2008-01-20 04:14:37 as **
  • Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
    British journal of pharmacology, Vol. 154, No. 3. (June 2008), pp. 529-541.
    by S Elliott
    posted to hypoxia epo by jyuh on 2008-09-12 03:38:54 as **
  • Erythropoietin in Cancer Patients.
    Annual review of medicine (3 November 2008)
    by John A A Glaspy
    posted to epo cancer by jyuh on 2008-12-01 09:22:26 as **
  • A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment.
    Health Technol Assess, Vol. 11, No. 13. (April 2007), pp. 1-220.
    posted to meta-analysis epo cancer anemia by jyuh on 2007-09-19 02:12:07 as **
  • Evidence and implications of haemoglobin cycling in anaemia management
    Nephrol. Dial. Transplant., Vol. 22, No. 8. (1 August 2007), pp. 2129-2132.
    by Steven Fishbane, Jeffrey S Berns
    posted to anemia epo longitudinal hd by jyuh on 2008-06-23 13:16:56 as **
  • Effect of a quality improvement strategy on several haemodialysis outcomes
    Nephrol. Dial. Transplant. (27 March 2008), gfn116.
    by Eduardo Parra, Rosa Ramos, Angels Betriu, Jose Paniagua, Montse Belart, Tomas Martinez
    posted to anemia cqi epo hd by jyuh on 2008-07-01 03:21:57 as ** along with 1 person drfothers
  • Exploring relative mortality and epoetin alfa dose among hemodialysis patients.
    Am J Kidney Dis, Vol. 51, No. 1. (January 2008), pp. 62-70.
    posted to anemia bias epo hd longitudinal mortality by jyuh on 2008-01-24 05:45:08 as **
  • Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.
    Blood, Vol. 111, No. 6. (15 March 2008), pp. 3229-3235.
    by K Takeda, HL Aguila, NS Parikh, X Li, K Lamothe, LJ Duan, H Takeda, FS Lee, GH Fong
    posted to epo hif phd by jyuh on 2008-07-16 07:30:30 as **
  • Health-related quality of life in the era of erythropoietin
    Hemodialysis International, Vol. 12, No. 1. (January 2008), pp. 6-15.
    by Steven D Weisbord, Paul L Kimmel
    posted to epo qol hd by jyuh on 2008-05-31 04:29:35 as **
  • Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
    J Am Soc Nephrol, Vol. 17, No. 4. (1 April 2006), pp. 1181-1191.
    by Deborah L Regidor, Joel D Kopple, Csaba P Kovesdy, Ryan D Kilpatrick, Charles J Mcallister, Jason Aronovitz, Sander Greenland, Kamyar Kalantar-Zadeh
    posted to anemia epo longitudinal mortality hd by jyuh on 2008-06-23 13:10:37 as **
  • HYPOXIA-INDUCED ERYTHROPOIETIN PRODUCTION: A PARADIGM FOR OXYGEN-REGULATED GENE EXPRESSION
    Clinical and Experimental Pharmacology and Physiology, Vol. 33, No. 10. (October 2006), pp. 968-979.
    posted to epo hypoxia by jyuh on 2008-07-16 07:53:53 as **
  • The Optimal Hemoglobin in Dialysis Patients- A Critical Review
    Seminars In Dialysis, Vol. 0, No. 0. (0000), pp. ???-???.
    by Ajay K Singh, Steven Fishbane
    posted to anemia epo hd by jyuh on 2007-09-03 16:59:22 as **
  • Development and exploitation of a clinical decision support system for the management of renal anaemia.
    Nephrol Dial Transplant, Vol. 22 Suppl 4 (June 2007)
    posted to anemia ckd epo by jyuh on 2007-11-05 05:17:03 as **
  • Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialysis population.
    Nephrol Dial Transplant, Vol. 15, No. 12. (December 2000), pp. 2007-2013.
    posted to anemia epo hd rct statistics by jyuh on 2007-11-05 05:30:52 as **
  • Anemia treatment in chronic kidney disease: shifting uncertainty.
    Heart failure reviews, Vol. 13, No. 4. (December 2008), pp. 425-430.
    by Marc A Pfeffer
    posted to anemia ckd epo by jyuh on 2008-06-17 05:29:17 as **
  • Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation.
    Kidney international, Vol. 71, No. 11. (June 2007), pp. 1163-1171.
    by AK Singh, DW Coyne, W Shapiro, AR Rizkala,
    posted to epo iron hd by jyuh on 2008-06-26 06:59:40 as **
  • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Eur J Cancer, Vol. 43, No. 2. (January 2007), pp. 258-270.
    posted to cancer epo by jyuh on 2007-09-19 02:11:44 as **
  • Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 23, No. 3. (March 2008), pp. 984-990.
    posted to ckd epo hd japan by jyuh on 2008-07-04 14:36:53 as **
  • Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
    Kidney international (2 July 2008)
    by Lynda A A Szczech, Huiman X X Barnhart, Jula K K Inrig, Donal N N Reddan, Shelly Sapp, Robert M M Califf, Uptal D D Patel, Ajay K K Singh
    posted to anemia epo hd rct by jyuh on 2008-07-05 06:13:08 as **
  • Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
    Transplantation, Vol. 83, No. 10. (27 May 2007), pp. 1371-1379.
    posted to hif epo arf by jyuh on 2008-09-12 03:34:45 as ** along with 1 person Unclescrooge
  • Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease.
    Nephrol Dial Transplant, Vol. 22 Suppl 4 (June 2007)
    by P Bárány, HJ Müller
    posted to anemia ckd epo by jyuh on 2007-11-05 05:13:02 as **
  • Hemoglobin Variability: Random Fluctuation, Epiphenomenon, or Phenomenon?
    Seminars in Dialysis, Vol. 19, No. 3. (May 2006), pp. 257-259.
    posted to anemia epo hd variability by jyuh on 2008-07-08 07:05:18 as **
  • Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Ann Pharmacother, Vol. 41, No. 11. (November 2007), pp. 1761-1769.
    by FW Maddux, S Shetty, MA del Aguila, MA Nelson, BM Murray
    posted to cea ckd epo by jyuh on 2008-03-16 00:14:20 as **
  • Association between erythropoietin responsiveness and body composition in dialysis patients.
    Blood purification, Vol. 26, No. 1. (2008), pp. 82-89.
    by P Kotanko, S Thijssen, NW Levin
    posted to hd bia epo obesity by jyuh on 2008-06-28 06:03:50 as **
  • Association between Erythropoietin Requirements and Antihypertensive Agents.
    Nephron. Clinical practice, Vol. 109, No. 1. (28 May 2008)
    by Shozo Yano, Keiko Suzuki, Masataka Iwamoto, Yoshinori Urushidani, Hiroyuki Yokogi, Masuo Kusakari, Akihiko Aoki, Masaaki Sumi, Kenjiro Kitamura, Hiromi Sanematsu, Masaru Gohbara, Sadao Imamura, Toshitsugu Sugimoto
    posted to epo ht hd by jyuh on 2008-06-26 06:58:27 as **
  • Stability of target hemoglobin levels during the first year of epoetin treatment in patients with chronic kidney disease.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 2, No. 5. (September 2007), pp. 938-946.
    posted to anemia epo longitudinal hd by jyuh on 2008-06-26 06:32:35 as **
  • Oxygen delivery enhancers: past, present, and future.
    Journal of endocrinological investigation, Vol. 31, No. 2. (February 2008), pp. 185-192.
    posted to hypoxia epo by jyuh on 2008-09-12 03:39:48 as **
  • Efficacy and safety of epoetin alfa in critically ill patients.
    The New England journal of medicine, Vol. 357, No. 10. (6 September 2007), pp. 965-976.
    by HL Corwin, A Gettinger, TC Fabian, A May, RG Pearl, S Heard, R An, PJ Bowers, P Burton, MA Klausner, MJ Corwin,
    posted to critical-care epo by jyuh on 2008-06-26 06:52:07 as ** along with 2 people ANB cchand
  • Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin
    J Am Soc Nephrol, Vol. 19, No. 2. (1 February 2008), pp. 372-379.
    by Toros Kapoian, Neeta B O'Mara, Ajay K Singh, John Moran, Adel R Rizkala, Robert Geronemus, Robert C Kopelman, Naomi V Dahl, Daniel W Coyne
    posted to epo hd iron by jyuh on 2008-02-11 09:26:00 as **
  • Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?
    Nature clinical practice. Nephrology (24 June 2008)
    by Rajiv Agarwal
    posted to epo hd iron by jyuh on 2008-07-05 04:49:36 as **
  • Hemoglobin variability: impact on anemia management practices.
    Nephrology nursing journal : journal of the American Nephrology Nurses' Association, Vol. 30, No. 4. (August 2003), pp. 456-459.
    posted to anemia epo hd variability by jyuh on 2008-07-08 07:05:04 as **
  • Antioxidative effects of erythropoietin.
    Kidney international. Supplement, No. 107. (November 2007)
    posted to ros epo by jyuh on 2008-09-12 03:20:57 as **
  • Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease.
    Kidney international (11 June 2008)
    by Sai Ram R Keithi-Reddy, Francesco Addabbo, Tejas V V Patel, Bharati V V Mittal, Michael S S Goligorsky, Ajay K K Singh
    posted to anemia ckd epo inflammation by jyuh on 2008-06-14 15:51:22 as **
  • Erythropoietin: physiology and molecular mechanisms.
    Heart failure reviews, Vol. 13, No. 4. (December 2008), pp. 405-414.
    by RN Foley
    posted to epo by jyuh on 2008-07-16 07:59:24 as **
  • The Role of Anemia Management in Improving Outcomes for African-Americans with Chronic Kidney Disease.
    American journal of nephrology, Vol. 28, No. 5. (24 April 2008), pp. 732-743.
    by Janice P P Lea, Keith Norris, Lawrence Agodoa
    posted to anemia ckd epo outcome by jyuh on 2008-06-17 05:33:50 as **
  • Functional Data Analysis Applied to a Randomized Controlled Clinical Trial in Hemodialysis Patients Describes the Variability of Patient Responses in the Control of Renal Anemia
    J Am Soc Nephrol, Vol. 18, No. 8. (1 August 2007), pp. 2371-2376.
    by Robert M West, Katie Harris, Mark S Gilthorpe, Cae Tolman, Eric J Will
    posted to anemia epo hd rct variability by jyuh on 2007-07-31 09:38:43 as **
  • Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease.
    Clinical nephrology, Vol. 69, No. 4. (April 2008), pp. 251-259.
    posted to anemia ckd epo outcome by jyuh on 2008-06-17 05:30:04 as **
  • Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
    Clin J Am Soc Nephrol, Vol. 2, No. 6. (November 2007), pp. 1274-1282.
    posted to anemia epo mortality hd by jyuh on 2008-01-08 04:11:08 as **
  • Hemoglobin variability in epoetin-treated hemodialysis patients.
    Kidney international, Vol. 64, No. 4. (October 2003), pp. 1514-1521.
    by JS Berns, H Elzein, RI Lynn, S Fishbane, IS Meisels, PB Deoreo
    posted to anemia epo hd variability by jyuh on 2008-07-08 07:04:29 as **
  • Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response
    Journal of Internal Medicine, Vol. 264, No. 5. (November 2008), pp. 405-432.
    by Brines, , Cerami,
    posted to epo ckd by jyuh on 2008-10-28 08:52:30 as **
  • Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
    J Am Soc Nephrol, Vol. 18, No. 5. (May 2007), pp. 1497-1507.
    by SH Park, MJ Choi, IK Song, SY Choi, JO Nam, CD Kim, BH Lee, RW Park, KM Park, YJ Kim, IS Kim, TH Kwon, YL Kim
    posted to emt epo tgfb uuo by jyuh on 2007-08-29 08:11:14 as **
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/tag/epo

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.